baber/WOPTO huggingface dataset:
Patent AU-2014236949-B2 (AU)
Title: Activation of bioluminescence by structural complementation
Inventor: DIXON ANDREW S
IPC: C07K14/435
Filed: 2014-03-13
Granted: 2018-08-02
Abstract: Provided herein are compositions and methods for the assembly of a bioluminescent complex from two or more non-luminescent (e.g., substantially non-luminescent) peptide and/or polypeptide units. In particular, bioluminescent activity is conferred upon a non-luminescent polypeptide via structural complementation with another, complementary non-luminescent peptide. Biological processes rely on covalent and non-covalent interactions between molecules, macromolecules and molecular complexes. In order to understand such processes, and to develop techniques and compounds to manipulate them for research, clinical and other practical applications, it is necessary to have tools available to detect and monitor these interactions.
Patent AU-2014240267-B2 (AU)
Title: Process for generating microwalled encapsulation balloons
Inventor: SHANNON DON
IPC: A61M31/00
Filed: 2014-10-02
Granted: 2016-10-13
Abstract: PROCESS FOR GENERATING MICROWALLED ENCAPSULATION A method and product thereby for generating a biocompatible balloon, comprising, in combination: compressing with a first die at least two porous membranes enclosed by a releasing agent between the first die and each of the at least porous membranes, wherein the releasing agent has a melting point above that of the porous membranes; heating the porous membranes to a temperature between the melting point of the porous membranes and the melting point of the releasing agent; and removing the first die; whereby the releasing agent provides support to the porous membranes by cohesive forces between the releasing agent and the porous membranes, such that the porous membranes maintain, after the compressing with the first die, a form defined by the compressing with the first die.
Patent AU-2014255949-B2 (AU)
Title: Use of comb polymers for controlling the rheology of mineral binder compositions
Inventor: FRUNZ LUKAS
IPC: C08F220/28
Filed: 2014-04-07
Granted: 2017-08-31
Abstract: A comb polymer is used for increasing the flow rate and/or reducing the viscosity of a mineral binder composition, where the comb polymer has a main chain comprising acid groups and there are pendent chains linked to the main chain, and where the average number-average molar mass of all of the pendent chains is from 120 to 1000 g/mol and the molar ratio of the acid groups to the side chains is in the range from 0.5 to 2.
Patent AU-2014257748-B2 (AU)
Title: Modified hydrogels
Inventor: HERSEL ULRICH
IPC: A61K9/10
Filed: 2014-04-16
Granted: 2018-11-01
Abstract: The present invention relates to a process for the preparation of a hydrogel suitable as carrier in a hydrogel-linked prodrug, to hydrogels obtainable from said process, the use of such hydrogel as a carrier in a hydrogel-linked prodrug and to hydrogel-linked prodrugs comprising a covalently conjugated hydrogel of the present invention. The hydrogel prodrug carrier has a reduced drug loading on the outside of the hydrogel carrier. This is achieved by reducing the number of functional groups of the hydrogel, in particular those at its surface.
Patent AU-2014265552-B2 (AU)
Title: Ophthalmic lens with a microfluidic system
Inventor: PUGH RANDALL B
IPC: G02C7/04
Filed: 2014-05-13
Granted: 2018-10-18
Abstract: The present invention described a system for an energized ophthalmic device with a media insert that includes microfluidic elements upon or within the media insert. In some embodiments, the microfluidic elements may be useful for the purpose of analyzing an analyte such as glucose in a fluid sample. In addition, some embodiments can function with a medicament administering device to treat an abnormal condition identified during the analyte analysis in the fluid sample.
Patent AU-2014292483-B2 (AU)
Title: Child safety seat
Inventor: HAAS MARTIN
IPC: B60N2/28
Filed: 2014-07-07
Granted: 2018-04-19
Abstract: The child safety seat (1) for a vehicle in accordance with the invention comprises an outer shell (2) enclosing a seating area (3) for a child (4) and a protective element (5). The protective element (5) comprises a housing component (7) and an impact component (8), wherein the housing component (7) is embedded into the outer shell (2) and the impact component (8) is mounted to the housing component (7), is configured to be enclosed at least partially by the housing component (7), and is configured to protrude laterally from the outer shell (2) in a direction facing away from the seating area (3). Preferably, the housing component (7) or the impact component (8) comprises a deformable region (9) adapted to cushion forces impacting on the impact component (8).
Patent AU-2014357155-B2 (AU)
Title: Quantitative evaluation method for reliability of markov model switch reluctance motor system
Inventor: CHEN HAO
IPC: G01R31/34
Filed: 2014-08-22
Granted: 2016-07-07
Abstract: A quantitative evaluation method for the reliability of a Markov model switch reluctance motor system. The method comprises: solving a probability matrix P
Patent AU-2015202117-B2 (AU)
Title: Merchandiser Including Accessible Canopy
Inventor: GRILL MICHAEL A
IPC: A47F3/04
Filed: 2015-04-24
Granted: 2017-03-30
Abstract: A refrigerated merchandiser including a case defining a product display area. The case includes a canopy defining an electrical raceway, and a panel that defines aesthetic fascia for the canopy. The panel is coupled to the canopy and movable between a first 5 position enclosing the electrical raceway and a second position providing access to the electrical raceway. The panel is cantilevered outward from adjacent a front of the canopy in the second position. 64235841 (GHMatters) P93227.AU.1 ROSG 24/04/15
Patent AU-2015202549-B2 (AU)
Title: Catheter with strain gauge sensor
Inventor: GOVARI ASSAF
IPC: A61N1/05
Filed: 2015-05-12
Granted: 2017-03-02
Abstract: A medical probe, including a flexible insertion tube, having a distal end for insertion into a body cavity of a patient and which is configured to be brought into contact with tissue in the body cavity. The probe further includes a sensor tube of an elastic material, contained inside the distal end of the insertion tube and configured to deform in response to forces exerted by the tissue on the distal end. The probe also includes a plurality of strain gauges fixedly attached to a surface of the sensor tube at different, respective locations and configured to generate respective signals in response to deformations of the sensor tube. 12/05/15,dh-22722 - abstract - cdm.docx,2
Patent AU-2015207570-B2 (AU)
Title: Method and device for setting data display
Inventor: RAFIZADEH SCHUMANN
IPC: G06F12/02
Filed: 2015-01-19
Granted: 2019-10-24
Abstract: A method and a device for setting data display are provided. The method includes establishing connections with at least one flash module array system and at least one display device, wherein the flash module array system comprises at least two flash modules and the display device comprises at least two display units; storing object information of at least one to-be-displayed object into the at least two flash modules, and establishing mappings between the at least two flash modules and the at least two display units to make a display unit display object information stored in a flash module corresponding to the display unit; and storing the mappings into the flash module array system. Thus, the efficiency and the flexibility of the display setting are improved.
Patent AU-2015210431-B2 (AU)
Title: Variable flow resistance system for use in a subterranean well
Inventor: FRIPP MICHAEL
IPC: E21B34/08
Filed: 2015-08-07
Granted: 2017-02-02
Abstract: A variable flow resistance system can include a flow chamber through which a fluid composition flows in a well, the chamber having an inlet and an outlet. The 5 fluid composition enters via the inlet in a direction which changes based on a ratio of desired to undesired fluid in the fluid composition. A well system can include a variable flow resistance system through which a fluid composition flows between a tubular string and a formation, the flow resistance system including a flow chamber through which the fluid composition flows, with only one chamber inlet. The fluid 10 composition flows more directly from the inlet to an outlet as a ratio of desired to undesired fluid in the fluid composition increases. Another flow resistance system can include at least one structure which influences portions of the fluid composition which flow circuitously between the inlet and the outlet to maintain such circuitous flow. 07/08/15,dh-22955 - abstract - cdm.docx,2
Patent AU-2015213332-B2 (AU)
Title: Pupil size-independent lens design and method for preventing and/or slowing myopia progression
Inventor: BRENNAN NOEL A
IPC: A61F2/16
Filed: 2015-08-13
Granted: 2020-06-18
Abstract: A lens includes a center of the ophthalmic lens having a negative power that provides foveal vision correction for myopia; a first peripheral zone surrounding the center having a power that gradually increases to a first peak having a dioptric power that is more positive than at the center; and a second peripheral zone surrounding the first peripheral zone and having a second peak having a dioptric power that is more positive than at the center and that is different than the power at the first peak. The power profile slows, retards, or prevents myopia progression independent of pupil size. 1l/OR/lS29Qfllnnnliclnewl1S Power Profile --LSA 1.50D m) Relative Power Energy LSA ,50DEP Dia (mm) -- - LSA 1.50D rmm
Patent AU-2015242190-B2 (AU)
Title: A liquid dispensing device
Inventor: BROWNE-WILKINSON OLIVER
IPC: B67D1/14
Filed: 2015-04-02
Granted: 2019-10-31
Abstract: Typical dispensers of liquids such as for beer often induce froth into the liquid as it is dispensed. This is not always desirable especially if too much froth is produced leading to waste. A liquid dispensing device (10) comprising a plurality of tubes (30) each tube having a diameter less than 2 mm is described to address the issue of over-frothing.
Patent AU-2015258301-B2 (AU)
Title: Vascular treatment device
Inventor: TAL MICHAEL
IPC: A61B17/22
Filed: 2015-11-20
Granted: 2018-02-22
Abstract: A vascular treatment device may include (1) a handle having a motor, a trigger, and a male coupling, and (2) a cartridge, engageable to the handle, having a female coupling, a wire, and a sheath fixed to the cartridge. When the female coupling is not engaged to the male coupling, the sheath may cover the distal end of the wire, allowing safe advancement of the device into the patient's vasculature, and when the female coupling is engaged by the male coupling, the distal end of the wire may be exposed from the sheath and used.
Patent AU-2015269667-B2 (AU)
Title: Methods of increasing tonic inhibition and treating secondary insomnia
Inventor: DURING MATTHEW
IPC: A61P25/00
Filed: 2015-06-03
Granted: 2020-07-30
Abstract: Methods of increasing tonic inhibition in a subject in need thereof, for example a subject with Fragile X syndrome or Angelman syndrome are disclosed. Methods of treating secondary insomnia in a subject with a neurodegenerative disease or disorder are also disclosed. The methods can include administering the subject an effective amount of 4,5,6,7- tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP) or a derivative thereof, or a pharmaceutically acceptable salt thereof, increase tonic inhibition in neurons of the subject; to increase slow wave sleep (SWS) and/or slow wave activity (SWA), normalize sleep architecture, reduce secondary insomnia, increase non-rapid eye movement (NREM) sleep, increase sleep continuity, enhance delta activity within NREM, increase or improve total sleep time (TST), increase or improve sleep efficiency, reduce total time awake (TAA), reduce number of awakenings (NWA), reduce latency to persistent sleep (LPS), or to reduce wake after sleep onset (WASO), in the subject, or any combination thereof.
Patent AU-2015283028-B2 (AU)
Title: A dispersion of (meth)acrylate copolymer containing a hydroxyalkyl (meth)acrylate functional monomer unit for flexible cementitious waterproofing materials
Inventor: YU MING HUA
IPC: C08F220/18
Filed: 2015-06-30
Granted: 2019-02-21
Abstract: The present invention relates to a dispersion of (meth)acrylate copolymer containing a hydroxyalkyl (meth)acrylate comonomer unit, which is obtained from polymerization of monomers comprising or consisting of, based on the total monomer weight, (a) from 25 to 45 % by weight of at least one monovinyl aromatic monomer and/or methyl methacrylate; (b) from 50 to 70% by weight of at least one C
Patent AU-2015317342-B2 (AU)
Title: Quantification and inventory management of expressed human breast milk
Inventor: ALVAREZ JEFFERY B
IPC: A23C9/152
Filed: 2015-09-18
Granted: 2019-07-11
Abstract: Systems, methods, and devices for milk expression are provided. In one aspect, a system includes an expression apparatus having an interface configured to engage a breast and an actuation assembly operably coupled to the interface. Actuation of the actuation assembly causes the interface to apply vacuum pressure against the breast to express milk from the breast. The system also includes various sensors for quantifying characteristics of the expressed milk, and a unique identifier allows inventory management of the expressed milk.
Patent AU-2016203279-B2 (AU)
Title: Decorative and/or secure element for homogeneous card construction
Inventor: CRAWFORD-TAYLOR SHANNON K
IPC: B32B15/08
Filed: 2016-05-20
Granted: 2016-12-01
Abstract: A laminate sheet includes a base film formed from a recyclable, biodegradable, degradable, and/or compostable material, a metal or reflective film layer disposed over film, and heat resistant layer disposed over the base film. C:\poi\word\SPEC-1 057923.docx
Patent AU-2016231544-B2 (AU)
Title: Weldless building structures
Inventor: DAYTON LIONEL E
IPC: E04B1/58
Filed: 2016-09-21
Granted: 2017-11-23
Abstract: A building structure including a first building member and a second building member may be connected by a plurality of fasteners, each fastener having a head, a threaded portion having a through hardness of between HRB 70 and HRC 40, a thread-forming portion of at least HRC 50 hardness enabling the fastener to form threads in at least the second steel building member, and a fluted lead portion of at least HRC 50 hardness with a nominal diameter between 70 and 95% of major diameter, such that the fastener is capable of providing a ratio of strip torque to thread-forming torque of at least 3.0 and a ratio of strip torque to drive torque greater than 6.0 when the second steel building member having a thickness of 0.25 inch and the fluted lead portion having at least one diameter within nominal diameter between 80 and 98% of major diameter. #17 Is' qq-p, --- U it, 1 p X'>
Patent AU-2016237984-B2 (AU)
Title: Gel type local anesthetic agent and gel type local anesthetic preparation using same
Inventor: IWAKIRI CHISATO
IPC: A61K31/704
Filed: 2016-01-07
Granted: 2019-01-31
Abstract: The gel local anesthetic agent according to the present invention is a local anesthetic agent comprising a local anesthetic having a tertiary amine and glycyrrhizic acid, wherein the local anesthetic and glycyrrhizic acid set to a gel to give a gel product.
Patent AU-2016261807-B2 (AU)
Title: Gas engine
Inventor: KISHIO KAZUMA
IPC: F02D19/02
Filed: 2016-05-13
Granted: 2019-09-19
Abstract: [Problem] To provide a gas engine that can control the air-fuel ratio in accordance with rapid calorie changes of a fuel gas. [Solution] The gas engine 1 comprises an A/F valve 22 and a solenoid valve 21, and is provided with a control unit 10 that conducts perturbation by the solenoid valve 21. The control unit 10 calculates an average opening bn on the basis of a predetermined number of local maximum openings bl and local minimum openings bs when perturbation control is conducted, conducts a control of closing the A/F valve 22 when the average opening bn is smaller compared to a predetermined target opening a, and conducts a control of opening the A/F valve 22 when the average opening bn is equal to or larger than the target opening a. When the control unit 10 senses a present opening of the solenoid valve 21 and when the present opening is determined to be continuously, for a predetermined number of times, equal to an upper limit opening bmax or a lower limit opening bmin of the solenoid valve 21, the average opening bn is substituted with the upper limit opening bmax or the lower limit opening bmin and then compared to the target opening a.
Patent AU-2016281957-B2 (AU)
Title: Factor XI antibodies and methods of use
Inventor: EDER JORG
IPC: C07K16/36
Filed: 2016-06-24
Granted: 2019-08-15
Abstract: The present invention relates to monoclonal antibodies and antigen binding fragments thereof that bind to human Factor XI and activated Factor XI ("Factor XIa"), and pharmaceutical compositions and methods of treatment comprising the same.
Patent AU-2016330663-B2 (AU)
Title: Gas turbine and compressor module for on-shore LNG plants
Inventor: GIANCOTTI MARCO
IPC: F01D25/28
Filed: 2016-09-26
Granted: 2020-07-23
Abstract: A modular gas turbine system for on-shore LNG plants is disclosed. The module com- prises a base plate (3) having a top side (3T) and a bottom side (3B) and supports on the top side thereof at least a gas turbine engine (5), a control and electrical room (33) wired to the gas turbine engine (5), at least part of auxiliaries of the gas turbine engine. Additionally, at least one compressor(23) is supported on the base plate (3) and me- chanically coupled to the gas turbine engine and driven into rotation by said gas turbine engine (5).
Patent AU-2016332236-B2 (AU)
Title: Pharmaceutical composition and application thereof
Inventor: GE CHUANSHENG
IPC: A61K31/454
Filed: 2016-09-28
Granted: 2019-04-11
Abstract: Disclosed are a pharmaceutical composition and an application thereof. The pharmaceutical composition includes one or more of a benzoheterocyclic compound as shown in formula (I), a pharmaceutically acceptable salt thereof, a solvate thereof, a crystalline form thereof, a co-crystal thereof, a stereoisomer thereof, an isotope compound thereof, a metabolite thereof and a prodrug thereof, and an androgen receptor pathway modulator. The pharmaceutical composition better inhibits prostate cancer cell growth.
Patent AU-2016340275-B2 (AU)
Title: Engineered work roll texturing
Inventor: BASSI CORRADO
IPC: B21B27/00
Filed: 2016-10-13
Granted: 2020-02-06
Abstract: Metal work rolls texturized with engineered textures can impart desired impression patterns on metal strips. Engineered textures can be controlled with particularity to achieve desired surface characteristics (e.g., lubricant trapping, coefficient of friction, or surface reflectivity) on work rolls and metal strips, and to allow for impression patterns to be imparted on metal strips during high percentages of reduction of thickness (e.g., greater than about 5% or greater than about 15%, such as around 30%-55%). Engineered textures can be applied by focusing energy beams at specific points of an outer surface of a work roll to impart texture elements on the work roll. In some cases, an engineered texture element that can be used to generate a generally circular impression element can be generally elliptical in shape, having a length that is shorter than its width by a factor dependent on the reduction of thickness percentage.
Patent AU-2016361499-B2 (AU)
Title: Methods and compositions for identifying and treating subjects at risk for checkpoint blockade therapy associated colitis
Inventor: PAMER ERIC
IPC: A61K35/66
Filed: 2016-11-23
Granted: 2021-11-04
Abstract: The present invention relates to methods and compositions for identifying subjects treated with or considered for treatment with checkpoint blockade therapeutic agents that are at higher or lower risk for developing checkpoint therapy associated colitis, by analyzing the intestinal microbiome of those subjects. It is based, at least in part, on the discovery that the abundance of certain intestinal microbiota of the phyla Bacteroidetes, including the bacteria in the families Bacteroidaceae, Rikenellaceae, and Barnesisllaceae, and/or an increase or decrease in microbial genetic pathways involved in polyamine transport and/or B vitamin biosynthesis (e.g., (riboflavin (B2), pantothenate (B5) and thiamine (B1)) are associated with the likelihood of developing checkpoint therapy associated colitis.
Patent AU-2016364624-B2 (AU)
Title: Carbon monoxide releasing norbornenone compounds
Inventor: SAMMUT IVAN ANDREW
IPC: C07C49/693
Filed: 2016-11-30
Granted: 2022-11-17
Abstract: The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.
Patent AU-2016416838-B2 (AU)
Title: Reduced diameter optical fiber and manufacturing method
Inventor: PASTOURET ALAIN
IPC: G02B6/036
Filed: 2016-07-29
Granted: 2021-08-12
Abstract: The invention relates to an optical fiber 1 comprising a core 2 and a cladding 3 surrounding the core 2 and having an outer diameter of 125μm, the optical fiber 1 comprising a cured primary coating 4 directly surrounding the cladding 3 and a cured secondary coating 5 directly surrounding the cured primary coating 4, said cured primary coating 4 having a thickness t
Patent AU-2017200912-B2 (AU)
Title: Lifting apparatus and associated methods
Inventor: REID JOSHUA NICHOLAS GEORGE
IPC: A61G7/10
Filed: 2017-02-10
Granted: 2019-02-21
Abstract: A lifting apparatus (10) and associated methods for raising a user in a body of water (22). The lifting apparatus (10) comprises a platform (16) configured to receive a wheelchair (12). The apparatus (10) is reconfigurable between a raised configuration; a 5 lowered configuration; and a storage configuration. The apparatus (10) is configured to maintain the platform (16) in a substantially horizontal orientation in the raised, lowered and storage configurations.
Patent AU-2017201378-B2 (AU)
Title: Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
Inventor: MANSOURI ZABRA
IPC: A61K9/16
Filed: 2017-02-24
Granted: 2018-07-19
Abstract: AB STRA CT! Dcrrn~flc~cii "TOpSifiOx a:e p)roviocd, A-v rp c mdrzd~j COmnplexes, where these complxcS include uniform rigid. shie ca nannporous calckui phnphate partcles dsociaed wit onc or more active 'n.Q Also proved are methods of uy in composiions in cve n dppicadons, 4118112 i.docx
Patent AU-2017202672-B2 (AU)
Title: A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
Inventor: JUNG SUNG YOUB
IPC: C07K17/00
Filed: 2017-04-21
Granted: 2019-01-17
Abstract: The present invention relates to a conjugate comprising oxyntomodulin, an immunoglobulin Fc region, and non-peptidyl polymer wherein the conjugate being obtainable by covalently linking oxyntomodulin to immunoglobulin Fc region via non-peptidyl polymer, and a pharmaceutical composition for the prevention or treatment of obesity comprising the conjugates. The conjugate comprising oxyntomodulin and the immunoglobulin Fc of the present invention reduces food intake, suppresses gastric emptying, and facilitates lipolysis without side-effects, unlike native oxyntomodulin, and also shows excellent receptor activating effects and long-term sustainability, compared to native oxyntomodulin. Thus, it can be widely used in the treatment of obesity with safety and efficacy.